Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Nov 5, 2015, after the close
10-Q filed Nov 5, 2015, 36 days after period end · 0000320017-15-000077
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2014 | Q3 2013 | Q3 2012 | Q3 2011 |
|---|---|---|---|---|
| Revenue | $5.89M | $4.12K | — | $4.43M |
| Net Income | -$11.38K | -$16.97K | -$9.07K | -$8.41M |
| EPS Diluted | -$2.06 |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$0.48 |
| -$0.45 |
| -$0.64 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
